July 14, 2017 / 6:36 AM / 10 days ago

BRIEF-Vitrolife Q2 EBITDA rises to SEK 112 mln

1 Min Read

July 14 (Reuters) - Vitrolife AB

* Q2 sales amounted to SEK 285 (208) million

* Q2 operating income before depreciation and amortisation (EBITDA) amounted to SEK 112 (74) million

* Says anticipates a constantly expanding market, which in monetary terms is expected to grow by 5-10 percent per year in the foreseeable future Source text for Eikon: Further company coverage: (Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below